Skull base osteomyelitis and bone defect induced by anti-resorptive agent-related osteonecrosis of the jaw in the mandible: A case report

被引:0
|
作者
Kanno, Chihiro [1 ]
Kanaya, Yoshiaki [1 ]
Yamazaki, Morio [1 ]
Yaginuma, Sadanoshin [1 ]
Watanabe, Yuki [1 ]
Kojima, Momoyo [1 ]
Kaneko, Tetsuharu [1 ]
机构
[1] Fukushima Med Univ Hosp, Dept Oral & Maxillofacial Surg, 1 Hikarigaoka, Fukushima, Fukushima 9601295, Japan
关键词
ARONJ; Skull base osteomyelitis; Osteonecrosis of jaw; Exacerbation; Temporal bone osteomyelitis; MEDICATION-RELATED OSTEONECROSIS; POSITION PAPER;
D O I
10.1016/j.ajoms.2023.04.003
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
A 57-year-old woman with a history of breast cancer and bone metastasis was referred to our hospital for pain following bone exposure surrounding the right molar teeth. As computed tomography (CT) revealed a periosteal reaction in that region, the condition was diagnosed as stage 2 anti-resorptive agent-related osteonecrosis of the jaw (ARONJ). She desired conservative therapy, not curative surgical therapy. However, ARONJ progressed with skin fistula formation in the external auditory canal and submandibular region, and more bacterial temporomandibular arthritis occurred. Twenty-five months later, she was admitted to the emergency department of our hospital for headache and fever. CT and magnetic resonance imaging revealed osteomyelitis of the temporal bone and extradural and brain abscess formation in the middle cranial fossa. Antibiotics were administered and craniotomy with drainage was performed, and the symptoms improved immediately after drainage. Ninety months after the diagnosis, mandibular bone exposure has increased markedly, and the temporal bone of the middle skull base shows a bone defect. This study suggests that ARONJ has the potential to lead to multiple complications.
引用
收藏
页码:34 / 37
页数:4
相关论文
共 14 条
  • [1] Predictive factors for refractory stage I and II anti-resorptive agent-related osteonecrosis of the jaw
    Shimizu, Takahiro
    Kim, Mai
    Dam, Trang Thuy
    Kurihara, Jun
    Ogawa, Masaru
    Makiguchi, Takaya
    Yokoo, Satoshi
    ORAL RADIOLOGY, 2022, 38 (02) : 240 - 251
  • [2] Incidence and Risk of Anti-Resorptive Agent-Related Osteonecrosis of the Jaw after Tooth Extraction: A Retrospective Study
    Shimizu, Rieko
    Sukegawa, Shintaro
    Sukegawa, Yuka
    Hasegawa, Kazuaki
    Ono, Sawako
    Nakamura, Tomoya
    Fujimura, Ai
    Fujisawa, Ayaka
    Nakano, Keisuke
    Takabatake, Kiyofumi
    Kawai, Hotaka
    Nagatsuka, Hitoshi
    Furuki, Yoshihiko
    HEALTHCARE, 2022, 10 (07)
  • [3] Predictive factors for refractory stage I and II anti-resorptive agent-related osteonecrosis of the jaw
    Takahiro Shimizu
    Mai Kim
    Trang Thuy Dam
    Jun Kurihara
    Masaru Ogawa
    Takaya Makiguchi
    Satoshi Yokoo
    Oral Radiology, 2022, 38 : 240 - 251
  • [4] Quantitative evaluation of anti-resorptive agent-related osteonecrosis of the jaw using bone single photon emission computed tomography in clinical settings: relationship between clinical stage and imaging
    Okui, Taro
    Kobayashi, Yoshikazu
    Tsujimoto, Masakazu
    Satoh, Koji
    Toyama, Hiroshi
    Matsuo, Koichiro
    ANNALS OF NUCLEAR MEDICINE, 2020, 34 (09) : 620 - 628
  • [5] Antiresorptive Agent-Related Osteonecrosis of the Jaw (ARONJ): A Twist of Fate in the Bone
    Shibahara, Takahiko
    TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2019, 247 (02) : 75 - 86
  • [6] Development of Antiresorptive Agent-Related Osteonecrosis of the Jaw After Dental Implant Removal: A Case Report
    Yamamoto, Shinsuke
    Maeda, Keigo
    Kouchi, Izumi
    Hirai, Yuzo
    Taniike, Naoki
    Yamashita, Daisuke
    Imai, Yukihiro
    Takenobu, Toshihiko
    JOURNAL OF ORAL IMPLANTOLOGY, 2018, 44 (05) : 359 - 364
  • [7] Antiresorptive agent-related osteonecrosis of the jaw in prostate cancer patients with bone metastasis treated with bone-modifying agents
    Nakai, Yasutomo
    Kanaki, Tomohiro
    Yamamoto, Akinaru
    Tanaka, Ryo
    Yamamoto, Yoshiyuki
    Nagahara, Akira
    Nakayama, Masashi
    Kakimoto, Ken-ichi
    Ishibashi, Miki
    Nishimura, Kazuo
    JOURNAL OF BONE AND MINERAL METABOLISM, 2021, 39 (02) : 295 - 301
  • [8] Antiresorptive agent-related osteonecrosis of the jaw in prostate cancer patients with bone metastasis treated with bone-modifying agents
    Yasutomo Nakai
    Tomohiro Kanaki
    Akinaru Yamamoto
    Ryo Tanaka
    Yoshiyuki Yamamoto
    Akira Nagahara
    Masashi Nakayama
    Ken-ichi Kakimoto
    Miki Ishibashi
    Kazuo Nishimura
    Journal of Bone and Mineral Metabolism, 2021, 39 : 295 - 301
  • [9] Antiresorptive agent-related osteonecrosis of the jaw risk in cancer patients before bone-modifying agent therapy: A retrospective study of 511 patients
    Kanno, Chihiro
    Kojima, Momoyo
    Tezuka, Yu
    Yaginuma, Sadanoshin
    Kanaya, Yoshiaki
    Kaneko, Tetsuharu
    BONE, 2023, 177
  • [10] Symposium: Imaging modalities for drug-related osteonecrosis of the jaw (6), assessment of mandibular metabolism due to long-term administration of an anti-resorptive agent by bone scintigraphy (secondary publication)
    Ohbayashi, Yumiko
    Nakai, Fumi
    Iwasaki, Akinori
    Ogawa, Takaaki
    Yamamoto, Yuka
    Nishiyama, Yoshihiro
    Miyake, Minoru
    JAPANESE DENTAL SCIENCE REVIEW, 2019, 55 (01) : 51 - 57